Glass Jacobson Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.1K Buy
1,957
+130
+7% +$3.4K 0.01% 337
2026
Q1
$51.3K Buy
1,827
+226
+14% +$6.02K 0.02% 312
2025
Q4
$39.9K Buy
1,601
+365
+30% +$9.2K 0.01% 334
2025
Q3
$31.5K Buy
1,236
+265
+27% +$6.54K 0.01% 350
2025
Q2
$23.5K Sell
971
-15,363
-94% -$358K 0.01% 371
2025
Q1
$433K Hold
16,334
0.14% 160
2024
Q4
$433K Sell
16,334
-3,501
-18% -$95K 0.14% 160
2024
Q3
$574K Sell
19,835
-509
-3% -$14.8K 0.19% 129
2024
Q2
$569K Sell
20,344
-650
-3% -$17.9K 0.21% 116
2024
Q1
$583K Sell
20,994
-564
-3% -$15.7K 0.22% 115
2023
Q4
$621K Buy
21,558
+24
+0.1% +$726 0.25% 105
2023
Q3
$714K Sell
21,534
-693
-3% -$24.5K 0.33% 92
2023
Q2
$815K Buy
+22,227
New +$865K 0.37% 79
2022
Q4
$1.23M Buy
+23,954
New +$1.15M 0.61% 44

Other funds holding PFE

Glass Jacobson Investment Advisors's PFE Position: Q2 2026 in Review

Glass Jacobson Investment Advisors increased its Pfizer (PFE) stake by 7.1% in Q2 2026, buying an estimated $3.4K and bringing the position to 1,957 shares worth $47.1K. The position accounts for 0.01% of the portfolio, ranked #337.

Glass Jacobson Investment Advisors first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.23M in Q4 2022. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Glass Jacobson Investment Advisors held 1,957 shares of Pfizer worth $47.1K as of Q2 2026.
  • Glass Jacobson Investment Advisors bought 130 Pfizer shares in Q2 2026, an estimated $3.4K.
  • Pfizer made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #337 holding.
  • Glass Jacobson Investment Advisors first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Pfizer position peaked at $1.23M in Q4 2022.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.